TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Barnekreftforeningen
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
61,379
|
50,230
|
53,685 |
| Financial expenses |
7
|
4
|
1 |
| Earnings before taxes |
25,135
|
7,573
|
15,400 |
| Total assets |
156,525
|
142,061
|
122,445 |
| Current assets |
145,900
|
130,565
|
111,371 |
| Current liabilities |
5,534
|
10,130
|
5,900 |
| Equity capital |
90,641
|
70,153
|
60,699 |
| - share capital |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
57.9%
|
49.4%
|
49.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
41.0%
|
15.1%
|
28.7% |
| Return on assets (ROA) |
16.1%
|
5.3%
|
12.6% |
| Current ratio |
2636.4%
|
1288.9%
|
1887.6% |
| Return on equity (ROE) |
27.7%
|
10.8%
|
25.4% |
| Change turnover |
14,477
|
-5,119
|
52,781 |
| Change turnover % |
31%
|
-9%
|
5836% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.